ATE237584T1 - Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung - Google Patents

Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung

Info

Publication number
ATE237584T1
ATE237584T1 AT97933680T AT97933680T ATE237584T1 AT E237584 T1 ATE237584 T1 AT E237584T1 AT 97933680 T AT97933680 T AT 97933680T AT 97933680 T AT97933680 T AT 97933680T AT E237584 T1 ATE237584 T1 AT E237584T1
Authority
AT
Austria
Prior art keywords
alpha
production
amino acid
acid amides
therapeutic use
Prior art date
Application number
AT97933680T
Other languages
English (en)
Inventor
Paolo Chiesi
Paolo Ventura
Maurizio Delcanale
Renato De Fanti
Elisabetta Armani
Gino Villetti
Claudio Pietra
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE237584T1 publication Critical patent/ATE237584T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT97933680T 1996-07-23 1997-07-15 Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung ATE237584T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI001544A IT1283489B1 (it) 1996-07-23 1996-07-23 Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
PCT/EP1997/003773 WO1998003472A1 (en) 1996-07-23 1997-07-15 Alpha-amino acid amides, preparation thereof and the therapeutical use thereof

Publications (1)

Publication Number Publication Date
ATE237584T1 true ATE237584T1 (de) 2003-05-15

Family

ID=11374651

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97933680T ATE237584T1 (de) 1996-07-23 1997-07-15 Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung

Country Status (26)

Country Link
US (1) US6114391A (de)
EP (1) EP0951465B1 (de)
JP (1) JP4542208B2 (de)
CN (1) CN1211351C (de)
AR (1) AR007963A1 (de)
AT (1) ATE237584T1 (de)
AU (1) AU729176B2 (de)
CA (1) CA2261259C (de)
CZ (1) CZ295824B6 (de)
DE (1) DE69721052T2 (de)
DK (1) DK0951465T3 (de)
ES (1) ES2195158T3 (de)
HU (1) HU225623B1 (de)
ID (1) ID17999A (de)
IL (1) IL128020A (de)
IT (1) IT1283489B1 (de)
MY (1) MY118244A (de)
NO (1) NO326826B3 (de)
NZ (1) NZ333869A (de)
PT (1) PT951465E (de)
RU (1) RU2174511C2 (de)
SI (1) SI0951465T1 (de)
TR (1) TR199900087T2 (de)
TW (1) TW557291B (de)
WO (1) WO1998003472A1 (de)
ZA (1) ZA976479B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672746A (en) 1994-08-30 1997-09-30 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
AU752192B2 (en) 1998-06-22 2002-09-12 American Biogenetic Sciences, Inc. The use of valproic acid analog for the treatment and prevention of migraine and affective illness
US20030035784A1 (en) * 2001-03-05 2003-02-20 Kao Corporation Hair cosmetic, aminocarboxylic acid amide and method for producing the same
DK1321139T3 (da) * 2001-12-21 2007-01-02 Chiesi Farma Spa 2-indanylaminoderivater til behandling af kronisk, akut eller inflammatorisk smerte
FR2843590B1 (fr) * 2002-08-14 2007-10-05 Prestwick Scient Capital Inc Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
WO2006016219A2 (en) * 2004-08-03 2006-02-16 Chiesi Farmaceutici S.P.A. Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
US9475757B2 (en) 2013-05-03 2016-10-25 Council Of Scientific & Industrial Research Synthesis of anti-Parkinson agent
CN105646252A (zh) * 2016-02-25 2016-06-08 吉尔生化（上海）有限公司 一种丝氨酸酰胺盐酸盐的合成方法
WO2020262996A1 (ko) * 2019-06-25 2020-12-30 (주)앰틱스바이오 신규한 아미노알칸산에 바이페닐기를 도입한 유도체 화합물 및 이를 포함하는 항진균성 약학적 조성물
WO2022238507A1 (en) * 2021-05-11 2022-11-17 Awakn Ls Europe Holdings Limited Therapeutic aminoindane compounds and compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3050800C2 (de) * 1979-03-22 1989-06-22 Continental Pharma Inc., Bruessel/Bruxelles, Be
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
EP0612751A3 (en) * 1988-03-16 1994-09-21 Eisai Co Ltd Compounds for the preparation of cephem derivatives.
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5198547A (en) * 1992-03-16 1993-03-30 South Alabama Medical Science Foundation, Usa Process for N5-formylating tetrahydropteridines
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
US5332840A (en) * 1993-05-27 1994-07-26 Bristol-Myers Squibb Company Method for preparing a benzaldehyde intermediate

Also Published As

Publication number Publication date
DE69721052T2 (de) 2004-02-05
SI0951465T1 (en) 2003-08-31
AU3695297A (en) 1998-02-10
US6114391A (en) 2000-09-05
CA2261259A1 (en) 1998-01-29
ZA976479B (en) 1998-03-02
NO326826B1 (no) 2009-02-23
NO990300D0 (no) 1999-01-22
CN1225625A (zh) 1999-08-11
EP0951465B1 (de) 2003-04-16
AR007963A1 (es) 1999-11-24
NO990300L (no) 1999-01-22
RU2174511C2 (ru) 2001-10-10
ES2195158T3 (es) 2003-12-01
DE69721052D1 (de) 2003-05-22
HUP9902992A3 (en) 2004-04-28
CN1211351C (zh) 2005-07-20
JP4542208B2 (ja) 2010-09-08
WO1998003472A1 (en) 1998-01-29
HU225623B1 (en) 2007-05-02
ITMI961544A1 (it) 1998-01-23
CZ18299A3 (cs) 1999-06-16
MY118244A (en) 2004-09-30
IT1283489B1 (it) 1998-04-21
EP0951465A1 (de) 1999-10-27
PT951465E (pt) 2003-08-29
AU729176B2 (en) 2001-01-25
IL128020A0 (en) 1999-11-30
ID17999A (id) 1998-02-19
NZ333869A (en) 2000-05-26
TW557291B (en) 2003-10-11
JP2001506577A (ja) 2001-05-22
CZ295824B6 (cs) 2005-11-16
CA2261259C (en) 2006-10-03
NO326826B3 (no) 2010-06-07
IL128020A (en) 2002-04-21
DK0951465T3 (da) 2003-08-11
TR199900087T2 (xx) 1999-03-22
ITMI961544A0 (de) 1996-07-23

Similar Documents

Publication Publication Date Title
DE69529026D1 (de) Trehalose, ihre Herstellung und ihre Verwendung
DE69710612T2 (de) Zeolith des im-5 -typs, dessen herstellung und katalytische verwendungen
ATE260343T1 (de) Bernsteinsäure herstellung und reinigung
DE69503139D1 (de) Schuhwerk und dessen herstellung
ATE432940T1 (de) Substituierte isochinolin-3-carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel
ID23600A (id) Turunan tiazolidin dan oksazolidin, pembuatan dan penggunaannya untuk pengobatan (pecahan dari p-950453)
DE69814431D1 (de) 3,3-diarylpropylamine , ihre verwendung und herstellung
DE69325552D1 (de) Manganoxide, ihre Herstellung und ihre Anwendung
DE69901177T2 (de) Platinkomplex, dessen herstellung und dessen therapeutische verwendung
DE69715210D1 (de) Modifiziertes mcm-56, seine herstellung und anwendung
DE60013021D1 (de) Herstellung von S,S und R,S Aminosäuren-Isosteren
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
DE69521595D1 (de) Optisch-aktives Benzothiepin-Derivate, ihre Herstellung und Verwendung
DE69526384D1 (de) Wasserabweisende Mittel, deren Herstellung und deren Anwendung
ATE237584T1 (de) Alpha-aminosäureamide, ihre herstellung und ihre therapeutische anwendung
DE59711704D1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung
DE69330075D1 (de) Oxazolinderivate, ihre Herstellung und Anwendung
DE69808921D1 (de) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG
DE69905714T2 (de) Platinkomplex, dessen herstellung und dessen therapeutische anwendung
DE69604071D1 (de) Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung
DE69611303D1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
DE59606132D1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung
DE69615396D1 (de) Derivate von 5-naphthalin-1-yl-1,3-dioxanen, ihre herstellung und therapeutische anwendung
DE69906680D1 (de) Citronnellyl- und/oder dihydrocitronellyllactate, ihre herstellung und ihre anwendung
DE69526154T2 (de) Herstellung von Organohaloboranen und Alkoxyorganoboranen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0951465

Country of ref document: EP

REN Ceased due to non-payment of the annual fee